THANK YOU FOR SUBSCRIBING
Jon DeVries has been appointed as the CEO of Paragon Biosciences, a life science innovator.
FREMONT, CA: Life science innovator Paragon Biosciences announces the appointment of Jon T. DeVries as the new chief executive officer of its portfolio company, Qlarity Imaging, a renowned artificial intelligence (AI) diagnostics company. A proven leader equipped with in-depth expertise in developing and commercializing medical imaging and AI solutions, Mr. DeVries’s duties will be to skilfully be responsible for executing Qlarity Imaging’s mission to advance breast cancer diagnosis with the AI-driven technology.
“Paragon serves as a catalyst and advisor to our portfolio companies to accelerate groundbreaking discoveries that help patients in need. With breast cancer remaining the second leading cause of cancer deaths in women, the need for improved care is undeniable,” said Jeff Aronin, founder, chairman, and chief executive officer of Paragon Biosciences. “Jon’s impressive background, along with his patient-centered approach and outstanding leadership talents, makes him well-suited to be at the helm of Qlarity Imaging as we seek to help patients live longer, healthier lives.”
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Mr. DeVries is equipped with more than 20 years of experience while spearheading the design and release of innovative cloud-based healthcare initiatives that have brought advanced services and technologies to solutions providers and researchers, having the ultimate goal of enhancing the quality of patient care. For instance, at Massachusetts General Hospital, he initiated a Tele3D service that enables any hospital in the country to access three-dimensional (3D) image analytics without paying the levied cost and the extensive cost of cultivating in-house 3D capabilities. While at IBM, he also developed technologies that deliver medical images anywhere at any time, providing suppliers a complete view of patients and their histories. He also created software that minimizes the time and cost of clinical trials. He also developed the first AI offering at IBM Watson Health Imaging that identifies patients with a potential misdiagnosis to ensure they receive the necessary cardiac care.
Mr. DeVries owns eight patents in the field of superconducting electronics, medical imaging, and AI. He has also served on the HIMSS Interoperability & Standards Committee, a collective effort to enhance patient care delivery by developing semantic interoperability and standards-oriented health IT systems.
“Developing the first diagnostic AI technology to be cleared by the U.S. Food and Drug Administration speaks volumes to Qlarity Imaging’s commitment to innovation in improving breast cancer diagnosis,” said Mr. DeVries. “Forward thinking is necessary to make bold scientific breakthroughs, and with Paragon’s support, we are poised to deliver better outcomes for the hundreds of thousands of women who are diagnosed with breast cancer each year.”
Mr. DeVries has obtained a Bachelor of Science in Physics from Harvey Mudd College and a Master of Business Administration in Finance and Operations from Columbia University-Columbia Business School.
More in News